Literature DB >> 25422237

A systematic review of cervical cancer incidence and mortality in the Pacific Region.

J Obel1, Y Souares, D Hoy, W Baravilala, S M Garland, S K Kjaer, A Roth.   

Abstract

This study provides the first systematic literature review of cervical cancer incidence and mortality as well as human papillomavirus (HPV) genotype prevalence among women with cervical cancer in the Pacific Island countries and territories. The cervical cancer burden in the Pacific Region is substantial, with age standardized incidence rates ranging from 8.2 to 50.7 and age standardized mortality rate from 2.7 to 23.9 per 100,000 women per year. The HPV genotype distribution suggests that 70-80% of these cancers could be preventable by the currently available bi- or quadrivalent HPV vaccines. There are only few comprehensive studies examining the epidemiology of cervical cancer in this region and no published data have hitherto described the current cervical cancer prevention initiatives in this region.

Entities:  

Mesh:

Year:  2014        PMID: 25422237     DOI: 10.7314/apjcp.2014.15.21.9433

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

1.  Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.

Authors:  J Obel; J McKenzie; L E Buenconsejo-Lum; A M Durand; A Ekeroma; Y Souares; D Hoy; W Baravilala; S M Garland; S K Kjaer; A Roth
Journal:  Asian Pac J Cancer Prev       Date:  2015

2.  LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1.

Authors:  Yan Feng; Luyun Qu; Xiuli Wang; Chunyan Liu
Journal:  Cancer Biol Ther       Date:  2019-08-07       Impact factor: 4.742

Review 3.  Novel Insight of CircRNAs in Cervical Cancer: Potential Biomarkers and Therapeutic Target.

Authors:  Maomao Wu; Yanxun Han; Xiangfei Gong; Ke Wan; Yuchen Liu; Yi Zhou; Lizhi Zhang; Guozheng Tang; Hui Fang; Bangjie Chen; Fan Yang; Qing Zhao; Genbao Wang; Chenghao Zhanghuang; Yunling Zhang
Journal:  Front Med (Lausanne)       Date:  2022-06-23

4.  Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.

Authors:  Liqiong Cai; Zehua Wang; Denghua Liu
Journal:  Tumour Biol       Date:  2015-12-02

5.  Breast and Cervical Cancer Screening in Palau: Have We Improved Early Detection and Survival?

Authors:  Irish M Tutii; Christine Roseveare; Kerri Viney; Haley L Cash; Tmong Udui; Edolem Ikerdeu
Journal:  Hawaii J Med Public Health       Date:  2017-12

6.  Human papillomavirus genotypes in Pacific Islander cervical cancer patients.

Authors:  T M Schisler; A K Bhavsar; B P Whitcomb; J H Freeman; M A Washington; J W Blythe; M A Nahid; C S Dietrich
Journal:  Gynecol Oncol Rep       Date:  2018-04-18

7.  The Prevalence and Associated Factors of Cancer Screening Uptake Among a National Population-Based Sample of Adults in Marshall Islands.

Authors:  Supa Pengpid; Chao Zhang; Karl Peltzer
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

8.  Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits.

Authors:  Yong-Wen Huang; Yun Zhou; Chun-Yan Lan; Yin Wang; Yan-Ling Feng; Rong-Zhen Luo; Ji-Hong Liu
Journal:  Drug Des Devel Ther       Date:  2015-11-05       Impact factor: 4.162

9.  Up-regulation of inflammation-related LncRNA-IL7R predicts poor clinical outcome in patients with cervical cancer.

Authors:  Yangyang Fan; Yan Nan; Juanjuan Huang; Hui Zhong; Weidong Zhou
Journal:  Biosci Rep       Date:  2018-06-12       Impact factor: 3.840

10.  Cervical cancer in Iran: integrative insights of epidemiological analysis.

Authors:  Zohre Momenimovahed; Hamid Salehiniya
Journal:  Biomedicine (Taipei)       Date:  2018-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.